- $54.15m
- $39.78m
- $527.11m
- 48
- 74
- 67
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 756 | 864 | 874 | 692 | 527 |
Cost of Revenue | |||||
Gross Profit | 546 | 614 | 545 | 370 | 323 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 737 | 870 | 1,171 | 895 | 675 |
Operating Profit | 18.9 | -6.3 | -297 | -203 | -148 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18.9 | -6.16 | -244 | -197 | -153 |
Provision for Income Taxes | |||||
Net Income After Taxes | 32.3 | -21.4 | -228 | -194 | -153 |
Net Income Before Extraordinary Items | |||||
Net Income | 32.3 | -21.4 | -228 | -194 | -153 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 31.9 | -21.4 | -228 | -194 | -153 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.39 | -3.7 | -28.6 | -28.4 | -18.6 |
Dividends per Share |